Benzinga | Nov 9, 2021 06:29PM EST

Aethlon Medical Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $131.97K Miss $190.00K Estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $131.97 thousand which missed the analyst consensus estimate of $190.00 thousand by 30.54 percent.